Lupin Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 203.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 202.62 Cr
as on 17-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 442.48%
(FY 2023)
- Profit -140.95%
(FY 2023)
- Ebitda -110.73%
(FY 2023)
- Net Worth -338.06%
(FY 2023)
- Total Assets 5.78%
(FY 2023)
About Lupin Diagnostics
The Corporate was formerly known as Lupin Healthcare Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 203.00 Cr and a paid-up capital of Rs 202.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lupin Diagnostics Limited India are Sunil Makharia as CFO and Amit Gupta as Company Secretary. Sunil Makharia, Manju Gupta, Nilesh Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2011PLC214885
- Company No.
214885
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2011
- Date of AGM
15 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lupin Diagnostics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Gupta  | Managing Director | 26-Aug-2011 | Current |
| Sunil Makharia | CFO | 01-Dec-2020 | Current |
| Amit Gupta | Company Secretary | 11-Sep-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swaminathan Ramesh | Director | Current | |
| Manju Gupta | Director | 12-May-2022 | Current |
| Sunil Makharia | Director and Cfo | 17-Mar-2011 | Current |
| Rajeev Sibal | Director | 15-Sep-2020 | Current |
Financial Performance of Lupin Diagnostics.
Lupin Diagnostics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 442.48% increase. The company also saw a substantial fall in profitability, with a 140.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 338.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lupin Diagnostics?
In 2023, Lupin Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lupin Digital Health LimitedActive 3 years 7 monthsSunil Makharia, Nilesh Gupta and 2 more are mutual person
Lupin Biologics LimitedActive 3 years 10 monthsNilesh Gupta and Swaminathan Ramesh are mutual person
Lupin Investments Private LimitedActive 40 years 3 monthsSunil Makharia and Nilesh Gupta are mutual person
Polynova Industries LimitedActive 38 years 2 monthsSunil Makharia and Nilesh Gupta are mutual person
Visiomed Investments Private LimitedActive 2 years 10 monthsSunil Makharia and Nilesh Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lupin Diagnostics?
Lupin Diagnostics has a workforce of 556 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lupin Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
